Chen Y.-Y.Peng F.-S.HO-HSIUNG LINHsiao S.-M.2021-03-032021-03-0320151028-4559https://www.scopus.com/inward/record.uri?eid=2-s2.0-84952872150&doi=10.1016%2fj.tjog.2014.06.004&partnerID=40&md5=3aeb9363900438f7f5abf92ff899d773https://scholars.lib.ntu.edu.tw/handle/123456789/550187[SDGs]SDG3CA 125 antigen; fluorodeoxyglucose f 18; hemoglobin; imatinib; abdominal distension; abdominal hysterectomy; adjuvant therapy; adult; anastomosis; Article; cancer adjuvant therapy; cancer chemotherapy; cancer diagnosis; cancer surgery; case report; colonoscopy; computer assisted tomography; cytoreductive surgery; differential diagnosis; female; follow up; frozen section; gastrointestinal stromal tumor; gastroscopy; hemoglobin blood level; histopathology; human; human tissue; laparotomy; middle aged; mitosis index; neurofibromatosis type 1; nuclear magnetic resonance imaging; ovary cancer; overall survival; positron emission tomography; salpingooophorectomy; surgical approach; treatment outcome; tumor volume; complication; Gastrointestinal Stromal Tumors; Ileal Neoplasms; neurofibromatosis type 1; Ovarian Neoplasms; Uterine Neoplasms; Diagnosis, Differential; Female; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Middle Aged; Neurofibromatosis 1; Ovarian Neoplasms; Uterine Neoplasmsjournal article10.1016/j.tjog.2014.06.004261663542-s2.0-84952872150